Liver Cancer Clinical Trials

A listing of Liver Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 744 clinical trials
None
Study on the Optimal Strategy for Acute-on-chronic Liver Failure With Integrative Treatment

Background: Acute-on-chronic liver failure (ACLF) is a syndrome characterized by acute deterioration in the setting of chronic liver disease associated with high short-term mortality. Currently, there is no specific treatment for patients with ACLF. Our previous results showed that Chinese herbal medicine (CHM) could reduce the mortality rate and the …

hepatitis
hepatic failure
acute on chronic liver failure
penta
cytokines
  • 4 views
  • 03 Feb, 2021
  • 15 locations
None
Antiviral Agents Against COVID-19 Infection

A key strategy in the treatment of COVID-19 would be to find an effective antiviral agent that would decrease the peak viral load and, consequently, the associated degree of immunopathological damage that follows this phase. The clinically approved substances considered for this study are used for treatment of other virus …

  • 0 views
  • 11 Nov, 2021
  • 1 location
None
Liver Cancer Community Education

This study proposes to bridge the gap between evidence and action and combat rising liver cancer rates attributed to Hepatitis B and C infection in Philadelphia by identifying neighborhoods with

hepatitis
Accepts healthy volunteers
  • 0 views
  • 14 Nov, 2021
  • 1 location
None
Infusion System for Hepatic Cancer

This is a single-site, open-label continued access study/treatment protocol under a treatment IDE. In addition to treating patients, the primary objective of this study is to assess the safety of using the Medtronic SynchroMed II programmable pump combined with the Intera tapered catheter for hepatic artery infusion (HAI) of a …

  • 0 views
  • 19 Feb, 2021
  • 1 location
None
DKN-01 Inhibition in Advanced Liver Cancer

This clinical trial is a prospective, open label, single arm oncological phase I/II trial in patients with hepatocellular carcinoma and WNT signaling alterations. The trial consists of two parts: Part A is a phase I study investigating the safety of DKN-01 administered as monoas well as combination therapy with sorafenib …

sorafenib
antiviral therapy
cancer
antiviral drugs
renal function
  • 35 views
  • 26 Jan, 2021
  • 8 locations
None
EXALT: EXercise Attenuates Liver Tumors Trial

The overall goal of this proposal is to test the effect of exercise to delay or avert HCC recurrence and gain information regarding the potential molecular mechanisms of HCC tumor inhibition by exercise.

liver transplant
hepatoma
  • 0 views
  • 01 Mar, 2021
  • 1 location
None
SBRT for Liver Cancer Before Liver Transplantation

Hepatocellular carcinoma (HCC) is the second commonest cause of cancer death worldwide. It is the third leading cause of cancer death in Hong Kong. Liver transplantation (LT) is the curative treatment of choice for HCC as it has the advantage of removing the tumour and also the premalignant cirrhotic liver. …

hepatocellular carcinoma
chemoembolization
carcinoma
anticoagulants
neutrophil count
  • 0 views
  • 25 Jan, 2021
  • 1 location
None
Plasmodium Immunotherapy for Breast and Liver Cancers

The purpose of this study is to evaluate the safety and preliminarily evaluate the effectiveness of Plasmodium immunotherapy for advanced breast cancers and advanced liver cancers.The treatment will last 4-6 weeks from the day of successful infection and will be terminated by antimalarial drugs.

blood count
  • 7 views
  • 22 Jan, 2021
  • 1 location
None
Standard Versus Radiobiologically-Guided Dose Selected SBRT in Liver Cancer

Radiation is a standard treatment option for patients with liver cancer. Unfortunately, the tumour grows after radiation in many patients and radiation can harm normal tissues. A new treatment

cancer
  • 0 views
  • 17 Sep, 2021
  • 1 location
None
Study of Pembrolizumab and Radiotherapy in Liver Cancer

This is a phase 2 study whose purpose is to assess the efficacy of the combination of pembrolizumab and stereotactic body radiotherapy (SBRT) in patients with advanced hepatocellular carcinoma (HCC) who have experienced disease progression after treatment with sorafenib.

hepatitis
sorafenib
hepatoma
measurable disease
cancer
  • 23 views
  • 01 Dec, 2021
  • 1 location